SI
ELV icon

Sava Infond’s Elevance Health ELV Stock Holding History

Sava Infond’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Sell
3,010
-7,350
-71% -$2.73M 0.08% 93
2026
Q1 		$3.03M Sell
10,360
-1,645
-14% -$541K 0.43% 54
2025
Q4 		$4.21M Sell
12,005
-2,000
-14% -$676K 0.57% 36
2025
Q3 		$4.53M Buy
14,005
+1,105
+9% +$344K 0.64% 30
2025
Q2 		$5.02M Buy
12,900
+700
+6% +$282K 0.78% 26
2025
Q1 		$5.31M Buy
12,200
+2,600
+27% +$1.04M 1.01% 21
2024
Q4 		$3.54M Buy
+9,600
New +$4.02M 0.63% 34

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Sava Infond's ELV Position: Q2 2026 in Review

Sava Infond reduced its Elevance Health (ELV) stake by 71% in Q2 2026, selling an estimated $2.73M and leaving 3,010 shares worth $1.16M. The position accounts for 0.08% of the portfolio, ranked #93.

Sava Infond first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.31M in Q1 2025. 293 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sava Infond held 3,010 shares of Elevance Health worth $1.16M as of Q2 2026.
  • Sava Infond sold 7,350 Elevance Health shares in Q2 2026, an estimated $2.73M.
  • Elevance Health made up 0.08% of Sava Infond's portfolio in Q2 2026, its #93 holding.
  • Sava Infond first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Elevance Health position peaked at $5.31M in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.